board of directors
Co-founder of CRESENCE AS and Chairman of the Board.
CEO of Pharmasum Therapeutics; Former Head of Business Development at Lytix Biopharma and Partner at Amino AS.
Former Worldwide Assistant Director of Clinical Development and Product Strategy at GSK for neurology; more than 20 years of experience in academia and industrial R&D.
Co-founder of CRESENCE AS and Vice-Chairman of the Board.
Medical Director Personalized Medicine Programmes (Swiss Federal Institute of Technology).
AURA Biopharm Board Member; Former CEO of GeNeuro SA (Euronext: gnro); Former Director BD and Medical Development at Serono/Merck KGaA.
Successful deal with AURA Biopharm; 20 years of pharma/biotech industry experience.
Co-founder of CRESENCE AS and Member of the Board.
Former Chief Development Officer of GeNeuro SA (Euronext: gnro).
Co-founder and CSO of Kenta Biotech (now Aridis Pharmaceuticals); Former Head Research Immunology Berna Biotech (now Johnson & Johnson); Professor of Immunology at the University of Bern.
Independent pharma and biotech consultant; more than 25 years of industry experience in product development.
board of scientific advisors
Co-founder of CRESENCE AS and CRESENCE Special Advisor.
Full Professor of General Pathology and Immunology, University of Catania, Italy.
He serves in the Editorial Boards of several international journals such as Antioxidants Basic and Clinical Pharmacology and Toxicology (European Journal of Pharmacology, Antioxidants and Redox Signalling).
Co-founder of GaNiAl Immunotherapeutic Inc. (USA), Onconox As (Denmark) and Aura Biopharm AS (Norway).
Successfull deals with all the 3 companies; 20 years of collaboration with pharmas and biotech companies.
prof. giuseppe scalabrino
CRESENCE AS Senior Advisor.
Professor of Pathology, University of Milano.
He has extensively published in the field of Neuro-inflammation and Repair and he has worked for many years on brain neuroregeneration.
Specialist in the mode of action and neuro-application of EGF.